Drugs / ROTAVIN-M1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2/3 | NCT01502969 Comparator | May 2010 → Sep 2011 | diarrheal disease | National Institute of Hygiene and Epidemiology, Vietnam | Completed | No outcome recorded |
| Phase 3 | NCT03703336 Comparator | Mar 2019 → Jan 2020 | Rotavirus infection, diarrheal disease | Center for Research and Production of Vaccines and Biologicals, Vietnam | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ROTAVIN-M1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03703336 ↗ |
| Modality | Vaccine | “Rotavin-M1 Vaccine” NCT01502969 ↗ |
| Route | Oral | “vaccine orally 8 weeks apart” NCT03703336 ↗ |